print

Country Report

Australia Flag Analgesics in Australia

| Pages: 20

Price: US$990

About this Report

Executive Summary

TRENDS

  • Analgesics is expected to witness healthy current value growth in 2015, with a high proportion of consumers making purchases in the category to ease their aches and pains. Analgesics are seen as a pantry essential and are taken regularly by consumers, further driven by the older population. Analgesics’ expected retail current value growth in 2015 of 5% is slightly below the review period CAGR of due to the impact of private label products and generics and the increasing presence of discount pharmacies.

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Australia is expected to be the leading player in analgesics in Australia in 2015, accounting for a 36% value share. In 2015, GlaxoSmithKline and Novartis created a consumer health joint venture as part of a three-part transaction in an effort to improve margins and focus on key businesses, with GlaxoSmithKline owning a 63% share in the new firm. Consequently, GlaxoSmithKline boosted its share in analgesics in 2015 by six percentage points with the addition of Novartis’ Voltaren and Fiorinal.

PROSPECTS

  • Analgesics is expected to see a 2% CAGR at constant 2015 prices over the forecast period, which is in line with the constant value growth seen over the review period. Aches, pains and migraines are a common occurrence and as such, analgesics are seen as a medical necessity. The category will continue to benefit from the ageing population, with the population aged 65+ expected to be the fastest-growing age segment over the forecast period according to Euromonitor International data.

GET MORE FOR LESS!


For orders of 3 or more reports, in addition to your multi-purchase discount, we will provide any strategy or global briefing absolutely free.

Please contact a web site agent using the chat box or complete the form here to receive your free strategic briefing. 



Samples (FAQs about samples):

doc_pdf.pngSample Analgesics Market Research Report

doc_excel_table.pngSample Analgesics Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Australia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Australia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Australia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Australia?
  • What are the major brands in Australia?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Analgesics in Australia - Category Analysis

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

CATEGORY DATA

  • Table 1 Sales of Analgesics by Category: Value 2010-2015
  • Table 2 Sales of Analgesics by Category: % Value Growth 2010-2015
  • Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2010-2015
  • Table 4 NBO Company Shares of Analgesics: % Value 2011-2015
  • Table 5 LBN Brand Shares of Analgesics: % Value 2012-2015
  • Table 6 Forecast Sales of Analgesics by Category: Value 2015-2020
  • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2015-2020

Consumer Health in Australia - Industry Context

EXECUTIVE SUMMARY

Consumer health delivers positive value growth in 2015

Calls for pharmacy deregulation

Mergers and acquisitions characterise the competitive environment

Discount pharmacies continue to increase presence

Proactive attitude to health is expected to support growth in consumer health

KEY TRENDS AND DEVELOPMENTS

Mergers and acquisitions characterise consumer health

Wearable technologies are expected to complement consumer health

Harper Review recommends pharmacy deregulation

MARKET INDICATORS

  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
  • Table 9 Life Expectancy at Birth 2010-2015

MARKET DATA

  • Table 10 Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2010-2015
  • Table 12 NBO Company Shares of Consumer Health: % Value 2011-2015
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2012-2015
  • Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2010-2015
  • Table 15 Distribution of Consumer Health by Format: % Value 2010-2015
  • Table 16 Distribution of Consumer Health by Format and Category: % Value 2015
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2015-2020
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2015-2020

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

  • Summary 1 OTC: Switches 2013-2015

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Segmentation

This market research report includes the following:

  • Analgesics
    • Systemic Analgesics
      • Adult Analgesics
        • Adult Acetaminophen
        • Adult Aspirin
        • Adult Combination Products - Analgesics
        • Adult Diclofenac
        • Adult Dipyrone
        • Adult Ibuprofen
        • Adult Ketoprofen
        • Adult Naproxen
        • Adult OTC Triptans
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Naproxen
      • Adult and Paediatric Systemic Analgesics
        • Acetaminophen
        • Aspirin
        • Combination Products - Analgesics
        • Diclofenac
        • Dipyrone
        • Ibuprofen
        • Ketoprofen
        • Naproxen
        • OTC Triptans
    • Topical Analgesics/Anaesthetic

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market Sizes
  • Company Shares
  • Brand Shares
  • Distribution
  • Analysis by Format
  • Herbal/Traditional vs Standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

print

Recently Viewed Items more ›

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!
    Our site uses cookies to improve functionality. Continue if you are happy with this or learn how to manage cookies by clicking here